PURPOSE: To evaluate the tolerance for and effectiveness of carbon ion radiotherapy in
patients with unresectable bone and soft tissue sarcomas. PATIENTS AND METHODS: We …

Purpose: To report the results of a Phase I/II clinical trial for patients with malignant gliomas,
treated with combined X-ray radiotherapy (XRT), chemotherapy, and carbon ion …

The aim of this study was to assess the feasibility of MET-PET as an evaluation method of
the therapeutic effect of carbon ion beam radiotherapy. Patients and Methods: Twenty-four …

The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world’s first heavy ion accelerator
complex dedicated to medical use in a hospital environment. Heavy ions have superior …

[en] The phase I/II clinical study of carbon ion radiotherapy (CIRT) for choroidal melanoma
was commenced in Jan. 2001 at the National Institute of Radiological Sciences (NIRS), which …

Bone and soft tissue sarcomas (BSTSs) represent a heterogeneous group of rare malignant
tumors with a wide spectrum in terms of histologic type, location, and outcome. Surgery, …

[en] The aim of this study is to evaluate the clinically relevant parameters for skin reactions
using DSH (dose surface histogram) in carbon ion radiotherapy of bone and soft tissue …

[en] This review describes the clinical features of recurrent rectal cancer (RC) and therapeutic
properties of heavy ion beam (HIB, here, carbon ion beam) and outcome of its clinical trials …

[en] In radiotherapy for prostate cancer, treatment outcome with both of high probability of
tumor control and low incidence of normal tissue morbidity is required. Carbon ion …

Until February 2003, a total of 1,463 patients were enrolled in clinical trials of carbon ion
radiotherapy. Most of the patients had locally advanced and/or medically inoperable tumors. …